Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Available × Neoplasms × 3-Iodobenzylguanidine × Clear all

Status

Completed 2 Unknown 1 Available 1 Approved for marketing 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 4 Recurrence 2 Pheochromocytoma 2 Paraganglioma 1 Neoplasms 1

Interventions

balstilimab 1 Proton Pump Inhibitors 1 Peripheral Blood Stem Cell Transplantation 1 LY3023414 1 Hydrocortisone 1 Bone Marrow Transplantation 1 3-Iodobenzylguanidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01370330 2025-07-22

131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol

University of California, San Francisco

Neoplasms, Neuroblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡